hsa-mir-378f: Hsa-mir-378f is a microRNA (miRNA) that has been identified as a significant element in various biological processes and diseases [PMC9180980]. This miRNA is notably downregulated in certain conditions, such as XELOX-chemotherapy-induced peripheral neuropathy, and has been associated with a substantial change in expression levels [PMC9180980], [PMC9523404]. It targets multiple genes, including IGF1R, and is involved in the regulation of numerous pathways [PMC6595612], [PMC7880712]. Hsa-mir-378f's expression was notably lower compared to control groups in certain studies, indicating its potential role as a biomarker for disease states or treatment responses [PMC9180980]. It was also identified as one of the miRNAs with the greatest expression changes among downregulated target miRNAs in specific disease conditions [PMC9523404]. Furthermore, hsa-mir-378f's interactions with long non-coding RNAs (lncRNAs) have been predicted through bioinformatics tools, suggesting its involvement in complex regulatory networks that could influence pathological changes and tumor development or progression based on the competing endogenous RNA (ceRNA) hypothesis [PMC9523404], [PMC9597465].